Best Nootropics for Calmness: L-Theanine, Ashwagandha, Saffron, Lemon Balm & Phosphatidylserine Compared
L-theanine, ashwagandha, saffron, lemon balm, and phosphatidylserine each target "calm" through a different pathway. Here's what the human trials actually used and found, where the evidence is thinner than it looks, and what FSSAI's rules say about each one.
Article Credibility
Written by: Swayam Loya, Pharmacist
Reviewed by: Dr. Annie Jain
Last reviewed: September 2026
Content standard: This article is educational and does not replace medical advice.
The Short Answer
Ashwagandha root has the most direct evidence for lowering cortisol and perceived stress of these five, and root extract is permitted by FSSAI (leaves are not). Saffron has the most striking mood data, mostly in people with low mood or diagnosed depression, and it appears in FSSAI's list of permitted botanicals. L-theanine promotes calm without sedation in small trials, but most of those trials used 200 mg or more, while FSSAI's nutraceutical schedule caps it at 100 mg per day. Lemon balm has small, dose-dependent human trials for calmness and anxiety. Phosphatidylserine has the most mixed evidence of the five, with some older trials using a cow-derived form that is no longer sold.
Key Takeaways
- Ashwagandha root: the clearest cortisol evidence, including a 60-day trial showing a 27.9% drop in serum cortisol at 600 mg/day, versus 7.9% on placebo.
- Saffron: 28 mg/day improved mood in adults with self-reported low mood; 22 mg/day did not. Its strongest trials are in depression, which is a medical condition that needs a doctor, not a supplement.
- L-theanine: calm-without-sedation in small trials, mostly at 200 mg or more. FSSAI's Schedule VI lists it at 50–100 mg/day, so Indian supplements sit below the most-studied calming dose.
- Lemon balm: 600 mg increased self-rated calmness during a lab stressor; 300 mg did not dull mental performance.
- Phosphatidylserine: inconsistent evidence for blunting the cortisol response to stress, and weaker for the soy- and sunflower-derived forms sold today.
- None of these treat an anxiety disorder or depression. If anxiety or low mood is persistent or affecting daily life, speak to a doctor.
In This Article
- L-theanine: calm alertness, not sedation
- Ashwagandha: the strongest cortisol evidence
- Saffron: striking mood data, with important caveats
- Lemon balm: small, dose-dependent trials
- Phosphatidylserine: the most mixed evidence
- How do these five actually compare?
- Who should be careful
- Frequently asked questions
- References and sources
These five ingredients all get filed under "calming," but they work through different systems: an amino acid from tea, an adaptogen that acts on the stress-hormone axis, a spice studied for mood, a traditional herb with mild anxiety-reducing effects, and a phospholipid studied for the body's cortisol response. Here's what's actually behind each one, including where the evidence is weaker than marketing usually suggests.
1. L-Theanine: Calm Alertness, Not Sedation
FSSAI status: Listed by name in FSSAI's Schedule VI of permitted nutraceutical ingredients, at 50–100 mg per day maximum.1
L-theanine is an amino acid found in tea leaves, and its defining feature is that it calms without making you drowsy. In a small 4-week randomized trial in 30 healthy adults, 200 mg/day was associated with reductions in stress-related symptoms and improvements in sleep scores, though the differences versus placebo were significant for only some of the measures.2 In a separate acute study, a single 200 mg dose reduced heart-rate and salivary stress-marker responses to a mental arithmetic stressor compared with placebo.3 The effects in these trials are modest and short-lived, and trials in people with diagnosed anxiety disorders remain few and small.
One detail that matters in India: most calming trials used 200 mg or more, but FSSAI permits up to 100 mg per day in nutraceuticals.1 A compliant Indian product will therefore sit below the dose most calming studies tested. The 100 mg level is the dose used in several caffeine-plus-theanine focus trials, which is a different use case, covered in our Calm Focus Combo article.
2. Ashwagandha: The Strongest Cortisol Evidence
FSSAI status: Root and root extract are permitted under Schedule IV, within prescribed limits. Leaves are not. FSSAI's advisory of 16 April 2026 restated that ashwagandha leaves may not be used in food products in any form, citing safety concerns linked to their higher Withaferin-A content.4
Of the five ingredients here, ashwagandha has the most direct evidence on the stress hormone itself. In a 60-day, double-blind, randomized, placebo-controlled trial, 64 adults with chronic stress took either 300 mg of root extract twice daily (600 mg/day) or a placebo. Serum cortisol fell by 27.9% in the ashwagandha group versus 7.9% on placebo, alongside significant drops in stress-questionnaire scores.5 A later systematic review and meta-analysis found consistent reductions in cortisol, stress, and anxiety measures across trials, although most trials were small and many used the same few branded extracts.6 Full dosing and safety detail, including pregnancy and thyroid precautions, is in our Ashwagandha 101 article.
3. Saffron: Striking Mood Data, With Important Caveats
FSSAI status: Saffron (Crocus sativus) appears in FSSAI's Schedule IV list of plant and botanical ingredients permitted in health supplements.1 It is also regulated separately as a food spice.
Saffron's most-cited data comes from people with diagnosed depression, not from healthy adults looking to feel calmer. In a small 6-week double-blind trial in patients with major depressive disorder with anxious distress, 30 mg/day of saffron performed similarly to the prescription antidepressant citalopram (40 mg/day), with no significant difference between the groups.7 That is one small trial in a clinical population. It is not a reason to use saffron instead of prescribed treatment, and depression should always be managed with a doctor.
The more relevant evidence for everyday low mood comes from a 4-week trial in 128 adults with self-reported low mood but no depression diagnosis. A standardized saffron extract at 28 mg/day significantly reduced negative mood and stress- and anxiety-related symptoms, while 22 mg/day did not separate from placebo, which suggests the effect depends on dose.8 Saffron's main compounds, crocins and safranal, are thought to act on serotonin, dopamine, and noradrenaline signaling, but that mechanism comes largely from laboratory and animal research.
4. Lemon Balm: Small, Dose-Dependent Trials
FSSAI status: Lemon balm (Melissa officinalis) is not listed by name in the FSSAI schedules we reviewed. If you're considering a lemon balm product, check that it carries a valid FSSAI licence number.
Lemon balm's human evidence is small but reasonably consistent. In a double-blind crossover study, a 600 mg dose reduced the negative mood effects of a laboratory stress test and increased self-rated calmness, while a 300 mg dose improved the speed of mental arithmetic without reducing accuracy.9 In other words, at these doses it did not trade calm for mental sluggishness the way a sedative would. Longer trials using higher doses, up to 3 g/day for 8 weeks in adults with stable angina, reported lower anxiety and stress ratings, though these were small studies in specific patient groups.10
5. Phosphatidylserine: The Most Mixed Evidence
FSSAI status: Phosphatidylserine is not listed by name in the FSSAI schedules we reviewed. As with lemon balm, check for a valid FSSAI licence number on any product.
Phosphatidylserine (PS) is a phospholipid found in cell membranes, especially in the brain. The early research on PS and the stress response used PS derived from cow brain, which is no longer sold because of concerns about mad cow disease. Today's products are made from soy or sunflower lecithin, and the evidence for these forms is thinner.11 Some small trials of soy-derived PS report a blunted cortisol response to exercise or laboratory stress, while others find no clear effect.11
In the US, the FDA allows only a qualified claim for PS and dementia risk, and requires it to state that the supporting evidence is very limited and preliminary.12 Taken together, PS is the least settled of these five for calm or stress.
| Ingredient | Most Reasonable Claim | Studied Dose | FSSAI Status |
|---|---|---|---|
| L-theanine | Modest, short-lived calm without sedation | 200 mg in most calming trials | Schedule VI, 50–100 mg/day max |
| Ashwagandha (root) | Reduced cortisol and perceived stress | 300–600 mg/day root extract | Root permitted (Schedule IV); leaves not permitted |
| Saffron | Improved mood in adults with low mood | 28–30 mg/day | Listed in Schedule IV |
| Lemon balm | Increased calmness under acute stress | 300–600 mg single dose | Not listed by name in schedules we reviewed |
| Phosphatidylserine | Possible blunting of stress cortisol (inconsistent) | Varies widely between trials | Not listed by name in schedules we reviewed |
How Do These Five Actually Compare?
If your main concern is ongoing stress, ashwagandha root has the most direct evidence and clear regulatory standing in India. If you want calm without drowsiness during the day, L-theanine is the best-matched option, with the caveat that Indian products are capped below the dose most calming trials used. If low mood rather than stress is the main issue, saffron has the most striking data, but persistent low mood deserves a conversation with a doctor before any supplement. Lemon balm has small but consistent trials for acute calmness. Phosphatidylserine has the weakest and most inconsistent evidence of the five.
Across all five, the studies are mostly small and short, typically lasting a few weeks. None of these ingredients has been shown to treat an anxiety disorder, and none replaces sleep, exercise, therapy, or medical care where those are needed.
Who Should Be Careful
- Pregnancy and breastfeeding: avoid ashwagandha, and avoid saffron above normal food amounts. Safety data for the others is limited, so check with a doctor first.
- Thyroid conditions: ashwagandha may raise thyroid hormone levels. Speak to your doctor if you have a thyroid condition or take thyroid medication.
- Antidepressants, sedatives, or sleep medication: saffron, ashwagandha, and lemon balm may add to the effects of these medicines. Don't combine them without medical advice.
- Under 18: these ingredients have been studied mainly in adults. Health supplements are not a substitute for support for a young person who is struggling with anxiety or low mood.
From save my brain.
save my brain. makes scientifically smart nootropics built by doctors to help overstimulated, digitally fatigued minds think clearly, sleep better, and focus deeper. Our first formula, focus., is available now.
Related reading: Ashwagandha 101 · Best Nootropics for Sleep · The Calm Focus Combo: L-Theanine + Caffeine · Anxiety vs Stress: What Is Different in Your Brain?
Frequently Asked Questions
Can saffron replace antidepressant medication?
No. One small 6-week trial found 30 mg/day of saffron performed similarly to citalopram in people with major depressive disorder, but a single small trial is not enough to replace prescribed treatment. Never stop or change antidepressant medication without your doctor.
Which of these five ingredients have clear FSSAI standing?
L-theanine is listed in FSSAI's Schedule VI at up to 100 mg per day. Ashwagandha root and saffron appear in the Schedule IV list of permitted botanicals, and ashwagandha leaves are not permitted. Lemon balm and phosphatidylserine were not listed by name in the schedules we reviewed.
How much L-theanine can a supplement contain in India?
FSSAI's Schedule VI lists L-theanine at 50–100 mg per day. Most trials on L-theanine for calm used 200 mg or more, so Indian supplements are capped below the most-studied calming dose.
Does phosphatidylserine actually lower cortisol?
The evidence is inconsistent. Early positive findings used cow-derived phosphatidylserine, which is no longer sold. Trials of today's soy- and sunflower-derived forms show mixed results, so it is the least established of these five for stress.
What's the difference between L-theanine and a sedative?
L-theanine is studied for promoting calm alertness rather than drowsiness, which is why it's often paired with caffeine. Sedatives work through different mechanisms and are designed to make you sleepy.
The Bottom Line
All five ingredients have some human evidence behind a calming effect, but the strength of that evidence varies a lot, and most of the trials are small and short. Ashwagandha root has the most direct stress-hormone evidence and clear standing in India. Saffron has striking mood data, mainly in people with low mood or depression. L-theanine offers mild calm without drowsiness, capped in India below its most-studied calming dose. Lemon balm has small but consistent trials, and phosphatidylserine remains the least settled. None of them treats anxiety or depression, and persistent symptoms deserve proper medical care.
Disclosure: save my brain. makes a nootropic supplement, focus., that contains L-theanine, one of the ingredients discussed below. We've tried to describe its evidence, including its limits, exactly as we would for any other ingredient.
Medical Disclaimer
This article is for educational purposes only and does not provide medical advice, diagnosis, or treatment. If anxiety, stress, or low mood is persistent or significantly affecting your daily life, please consult a qualified healthcare professional. This product is not intended to diagnose, treat, cure, or prevent any disease.
References and Sources
- FSSAI. Implementation of Food Safety and Standards (Health Supplements, Nutraceuticals…) Regulations, 2016, including Schedule IV (botanicals) and Schedule VI (nutraceutical ingredients).
- Hidese S. et al. (2019). Effects of L-Theanine Administration on Stress-Related Symptoms and Cognitive Functions in Healthy Adults: A Randomized Controlled Trial. Nutrients.
- Kimura K. et al. (2007). L-Theanine reduces psychological and physiological stress responses. Biological Psychology.
- FSSAI (16 April 2026). Advisory on non-use of Ashwagandha leaves in crude or extract or any other form in food products.
- Chandrasekhar K. et al. (2012). A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root in reducing stress and anxiety in adults. Indian Journal of Psychological Medicine.
- Effects of Ashwagandha Supplements on Cortisol, Stress, and Anxiety Levels in Adults: A Systematic Review and Meta-Analysis.
- Ghajar A. et al. (2017). Crocus sativus L. versus Citalopram in the Treatment of Major Depressive Disorder with Anxious Distress: A Double-Blind, Controlled Clinical Trial. Pharmacopsychiatry.
- Kell G. et al. (2017). affron®, a novel saffron extract (Crocus sativus L.), improves mood in healthy adults over 4 weeks in a double-blind, parallel, randomized, placebo-controlled clinical trial. Complementary Therapies in Medicine.
- Kennedy D.O. et al. (2004). Attenuation of laboratory-induced stress in humans after acute administration of Melissa officinalis (Lemon Balm). Psychosomatic Medicine.
- Clinical Efficacy and Tolerability of Lemon Balm (Melissa officinalis L.) in Psychological Well-Being: A Review.
- Glade M.J. & Smith K. (2015). Phosphatidylserine and the human brain. Nutrition.
- U.S. Food and Drug Administration. Qualified Health Claims: Letters of Enforcement Discretion (including phosphatidylserine and cognitive dysfunction and dementia).